Concepedia

Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)

Kengo Takeuchi, Yosuke Togashi, Yuki Kamihara, T. Fukuyama, Hiroshige Yoshioka, Akira Inoue, H Katsuki, Katsuyuki Kiura, Kazuhiko Nakagawa, Takashi Seto,

Annals of Oncology · 2015 · 58 citations · 15 references

DOIFull text

Open access

Concepts

References

15

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

Manabu Soda, Young Lim Choi, Munehiro Enomoto et al. · Nature · 2007 · 5.4K citations

, , +14

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge et al. · New England Journal of Medicine · 2010 · 4.5K citations

, , +14

RET, ROS1 and ALK fusions in lung cancer

Kengo Takeuchi, Manabu Soda, Yuki Togashi et al. · Nature Medicine · 2012 · 1.3K citations

, , +14

KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer

Kengo Takeuchi, Young Lim Choi, Yuki Togashi et al. · Clinical Cancer Research · 2009 · 712 citations

, , +17

<i>ALK</i> Rearrangements Are Mutually Exclusive with Mutations in <i>EGFR</i> or <i>KRAS</i>: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer

Justin F. Gainor, Anna M. Varghese, Sai‐Hong Ignatius Ou et al. · Clinical Cancer Research · 2013 · 608 citations · Full text

, , +14